Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.01.2023 | Case report

Clozapine/hydroxychloroquine

QTc prolongation, lack of efficacy and off-label use: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Amazan R, et al. Hydroxychloroquine induced QT prolongation in a schizoaffective patient being treated for a COVID-19 infection: A Case Report. European Psychiatry 65 (Spec. issue 1): S714 (plus poster) abstr. EPV1150, Jun 2022. Available from: URL: http://doi.org/10.1192/j.eurpsy.2022.1840 [abstract] Amazan R, et al. Hydroxychloroquine induced QT prolongation in a schizoaffective patient being treated for a COVID-19 infection: A Case Report. European Psychiatry 65 (Spec. issue 1): S714 (plus poster) abstr. EPV1150, Jun 2022. Available from: URL: http://​doi.​org/​10.​1192/​j.​eurpsy.​2022.​1840 [abstract]
Metadaten
Titel
Clozapine/hydroxychloroquine
QTc prolongation, lack of efficacy and off-label use: case report
Publikationsdatum
01.01.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-30570-9

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Azd-1222

Case report

Antineoplastics

Case report

Methylphenidate